1.44
Schlusskurs vom Vortag:
$1.56
Offen:
$1.6
24-Stunden-Volumen:
364.26K
Relative Volume:
0.07
Marktkapitalisierung:
$5.31M
Einnahmen:
$513.90K
Nettoeinkommen (Verlust:
$-48.50M
KGV:
-0.0514
EPS:
-28.0101
Netto-Cashflow:
$-28.99M
1W Leistung:
-31.43%
1M Leistung:
-53.55%
6M Leistung:
-64.22%
1J Leistung:
-87.42%
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 438-1036
Adresse
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CODX
Co Diagnostics Inc
|
1.44 | 7.52M | 513.90K | -48.50M | -28.99M | -28.01 |
|
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
CODX Looks 3.8% Undervalued on GF Value™ as Market Prices in Cha - GuruFocus
Co-Diagnostics Joint Venture CoSara provides Ebola Test Kits for analytical studies - BioSpectrum Asia
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Benzinga
Co-Diagnostics, Inc. Announces Amendment to Equity Distribution Agreement with Maxim Group LLC – July 2026 SEC Filing Update – Minichart - Minichart
Co-DiagnosticsAmends Equity Distribution Agreement With Maxim Group For Common Stock SaleSEC Filing - TradingView
Co-Diagnostics Updates ATM With Maxim, Extends Share Standstill to Aug. 14, 2026 - TradingView
Co-Diagnostics Inc (CODX) Cash Flow - TradingKey
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics Inc (CODX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Co-Diagnostics Inc (CODX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Co-Diagnostics Inc (CODX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Co-Diagnostics, Inc. Revenue Breakdown – MUN:C970 - TradingView
CODX|Co-Diagnostics Inc|Price:2.100|Chg%:-0.110 - TradingKey
Co-Diagnostics Inc (CODX) Balance Sheet - TradingKey
Co-Diagnostics Inc (CODX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Co-Diagnostics Inc (CODX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Co-Diagnostics, Inc. Revenue Breakdown – LS:A41UNJ - TradingView
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX: Co-Diagnostics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Co-Diagnostics Inc (CODX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Co-diagnostics Company Profile & Introduction - Moomoo
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics joint venture begins TB test clinical studies in India By Investing.com - Investing.com South Africa
Co-Diagnostics joint venture begins TB test clinical studies in India - Investing.com Nigeria
Co-Diagnostics launches TB test clinical trials on PCR Pro devices in India labs - Pluang
Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test - marketscreener.com
About 30-Minute TB Test Enters Evaluation in Indian Labs - Stock Titan
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin - Benzinga
Form DEF 14A CO-DIAGNOSTICS For: 21 July By Investing.com - Investing.com Nigeria
$2.45 | Co-Diagnostics, Inc. Common Stock (CODX) Stock Price Today - Binance
Co-Diagnostics names Wes Lindsey as chief scientific officer - Investing.com India
Co-Diagnostics names Wes Lindsey as chief scientific officer By Investing.com - Investing.com South Africa
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - Finviz
Co-Diagnostics Names New Chief; Co-Dx PCR Is Not Yet for Sale - Stock Titan
Form PRE 14A CO-DIAGNOSTICS For: 10 July By Investing.com - Investing.com South Africa
Co‑Diagnostics seeks shareholder approval to add 2.0M shares to equity plan | CODX SEC FilingForm PRE 14A - Stock Titan
Co-Diagnostics to show TB test platform at UN workshop in Bangkok - Stock Titan
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand - PR Newswire
Why did CODX stock surge 45% in pre-market today? - MSN
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):